A comprehensive list of 70 cancer-related genes for patients with solid tumors, including prostate and bladder cancers
MSI STATUS
Includes microsatellite instability high (MSI-H) status to help you identify patients for immunotherapy
STREAMLINED REPORT
Streamlined report to help you identify therapies and clinical trial options for more patients
To
help guide therapy selection and identify clinical trial options for
more patients, FoundationOne Liquid tests for guideline recommended
genes and biomarkers for patients with prostate cancer, including BRCA1, BRCA2, ATM, PALB2, CHEK2,
and MSI-H. One simple blood draw also includes testing for FGFR
alterations, which may indicate eligibility for targeted therapy for
metastatic bladder cancer patients.
Each
test requires only two 8.5mL tubes of blood, with the option to request
mobile phlebotomy for in-home blood draw at your patient's
convenience.B9
Questions?
We're here to help. Call Foundation Medicine Client Services at (888)
988-3639 between 8:00am ET and 8:00pm ET, Monday through Friday.
1. If requested and available, Foundation Medicine will arrange for mobile phlebotomy at no additional cost.
Foundation Medicine 150 Second Street, Cambridge, MA 02141
B)2019 Foundation Medicine, Inc. | FoundationOneB. is a registered trademark of Foundation Medicine, Inc.
Foundation Medicine 150 Second Street Cambridge MA 02141
